The stock of healthcare company Humana ( HUM) has broken its uptrend for 2022 and turned lower. Let's review the charts and indicators and set a new strategy for the first quarter.
In the daily bar chart of HUM, below, I see weak prices headed down for a test of the rising 200-day moving average line. HUM is trading below the cresting 50-day moving average line. The trading volume has been heavier since the middle of September, which might suggest that some traders used the rally to nail down profits.
The daily On-Balance-Volume (OBV) line has turned lower in December. The Moving Average Convergence Divergence (MACD) oscillator is in a bearish alignment below the zero line. 
In the weekly Japanese candlestick chart of HUM, below, I can see some upper shadows above $550. Upper shadows tell you that traders rejected the highs. The 40-week moving average line is in an uptrend but could be tested soo as prices pull back.
The On-Balance-Volume (OBV) line has been stalled the past five months. The MACD oscillator has crossed to the downside for a take profit sell signal.
In this daily Point and Figure chart of HUM, below, I can see a potential downside price target in the $433 area.
In this weekly Point and Figure chart of HUM, below, I can see the same downside price target as on the daily chart above -- $433.
Bottom-line strategy: A weekly close below $480 on HUM is likely to precipitate further declines. Avoid the long side.
